Immunome to Present at the H.C. Wainwright 27th Annual Global Investment Conference

(NASDAQ:IMNM) BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Immunome management will present at the H.C. Wainwright 27th Annual Global Investment Conference on Tuesday, Sept. 9, 2025 at 1:00 p.m. Eastern Time. Interested parties can access the live audio webcast for this conference from the Investor Relations section of the company’s website at www.immunome.com. The